The Leukemia and Bone Marrow Failure Program at Weill Cornell Medicine/NewYork-Presbyterian is a comprehensive program with nationally and internationally recognized specialists who treat malignant bone marrow diseases. These include acute and chronic leukemias, such as acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), as well as other, rare types of leukemia including myelodysplastic syndrome and myeloproliferative disorders. Our expert team is also dedicated to treating bone marrow failure.

The Weill Cornell Leukemia Program uses a multidisciplinary approach to provide world-class clinical care in collaboration with our colleagues specializing in the treatment of lymphoma, myeloma, and other blood disorders. We view each person as an individual, and our emphasis on providing highly personalized, individual care ensures that each treatment plan is designed to meet the unique needs of each of our patients and their families. A diagnosis of leukemia or bone marrow failure can affect your whole body physically and emotionally, so we have developed an outstanding team that includes specialists in infectious diseases, geriatrics, gastroenterology, cardiology, nephrology, neurology, pulmonary and critical care medicine, psychiatry, social work, nutrition and other supportive services.